TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Effect of Mental Training on Childbirth Measured on Pain Experience and Other Birth Outcomes
Brief Summary: Labour pain is a challenge to the parturient woman. Pain relief methods during birth are limited and often associated with side effects. Several studies indicate that a mental trainings method, self hypnosis, has a positive impact on the labour pain and other birth outcomes.

The aim of this randomized controlled study is to examine the effect of a short antenatal course in self hypnosis on the use of epidural analgesia during birth and several other birth outcomes. Data collection includes questionnaires, register data, medical records and biological material.


Options:
A: Arm Label: antenatal classes in self hypnosis; Type: EXPERIMENTAL; Interventions: Behavioral: Self hypnosis | Arm Label: relaxation and awareness; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Self hypnosis | Arm Label: Control; Type: OTHER; Interventions: Behavioral: Self hypnosis | Intervention Type: BEHAVIORAL; Name: Self hypnosis; Assigned to Arm(s): Control, antenatal classes in self hypnosis, relaxation and awareness
B: Arm Label: Psychoeducative group therapy; Type: EXPERIMENTAL; Interventions: Behavioral: Psychoeducative group therapy | Arm Label: Control; Type: NO_INTERVENTION; Interventions: Behavioral: Psychoeducative group therapy | Intervention Type: BEHAVIORAL; Name: Psychoeducative group therapy; Assigned to Arm(s): Control, Psychoeducative group therapy
C: Arm Label: Fear of childbirth, music; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Music | Arm Label: Fear of childbirth, control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Nulliparous, music; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Music | Arm Label: Nulliparous, control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Music; Assigned to Arm(s): Fear of childbirth, music, Nulliparous, music
D: Arm Label: Art therapy group; Type: EXPERIMENTAL; Interventions: Other: Art Therapy and therapeutic conversations | Arm Label: Therapeutic conversation group; Type: ACTIVE_COMPARATOR; Interventions: Other: Therapeutic conversations | Intervention Type: OTHER; Name: Art Therapy and therapeutic conversations; Assigned to Arm(s): Art therapy group | Intervention Type: OTHER; Name: Therapeutic conversations; Assigned to Arm(s): Therapeutic conversation group

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized Clinical Trial of the Effect of Five-years Versus Two-years Specialized Assertive Intervention for First Episode Psychosis - the OPUS II Trial
Brief Summary: In a randomized clinical trial, the researchers want to investigate if the positive short-term outcomes (first 1-2 years), achieved with specialized assertive intervention programme (OPUS), can be maintained for five years if the specialized treatment is sustained over the first five years in comparison to only two years of specialized treatment followed by three years of standard treatment.


Options:
A: Arm Label: 5 year; Type: EXPERIMENTAL; Interventions: Behavioral: OPUS 5 years | Arm Label: 2 years of OPUS treatment; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: 2 years OPUS treatment | Intervention Type: BEHAVIORAL; Name: 2 years OPUS treatment; Assigned to Arm(s): 2 years of OPUS treatment | Intervention Type: BEHAVIORAL; Name: OPUS 5 years; Assigned to Arm(s): 5 year
B: Arm Label: Integrated Treatment; Type: EXPERIMENTAL; Interventions: Behavioral: Integrated Treatment | Arm Label: Community Care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Community Care | Intervention Type: BEHAVIORAL; Name: Integrated Treatment; Assigned to Arm(s): Integrated Treatment | Intervention Type: BEHAVIORAL; Name: Community Care; Assigned to Arm(s): Community Care
C: Arm Label: Individual psychoeducation; Type: EXPERIMENTAL; Interventions: Other: Individual psychoeducation | Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Other: Control | Intervention Type: OTHER; Name: Control; Assigned to Arm(s): Control | Intervention Type: OTHER; Name: Individual psychoeducation; Assigned to Arm(s): Individual psychoeducation
D: Arm Label: Case Management (1 year); Type: EXPERIMENTAL; Interventions: Behavioral: Community Case Management | Arm Label: Standard Care (1 year); Type: NO_INTERVENTION; Interventions: Behavioral: Community Case Management | Intervention Type: BEHAVIORAL; Name: Community Case Management; Assigned to Arm(s): Case Management (1 year), Standard Care (1 year)

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized Clinical Trial of the Effect of Five-years Versus Two-years Specialized Assertive Intervention for First Episode Psychosis - the OPUS II Trial
Brief Summary: In a randomized clinical trial, the researchers want to investigate if the positive short-term outcomes (first 1-2 years), achieved with specialized assertive intervention programme (OPUS), can be maintained for five years if the specialized treatment is sustained over the first five years in comparison to only two years of specialized treatment followed by three years of standard treatment.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Contingency Management | Arm Label: 2; Type: OTHER; Interventions: Behavioral: Non Contingent Control Condition | Intervention Type: BEHAVIORAL; Name: Contingency Management; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Non Contingent Control Condition; Assigned to Arm(s): 2
B: Arm Label: 5 year; Type: EXPERIMENTAL; Interventions: Behavioral: OPUS 5 years | Arm Label: 2 years of OPUS treatment; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: 2 years OPUS treatment | Intervention Type: BEHAVIORAL; Name: 2 years OPUS treatment; Assigned to Arm(s): 2 years of OPUS treatment | Intervention Type: BEHAVIORAL; Name: OPUS 5 years; Assigned to Arm(s): 5 year
C: Arm Label: 2; Type: EXPERIMENTAL; Interventions: Behavioral: Cognitive training | Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Cognitive training | Intervention Type: BEHAVIORAL; Name: Cognitive training; Assigned to Arm(s): 1, 2
D: Intervention Type: BEHAVIORAL; Name: Integrated treatment, family involvement; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: Social skills training; Assigned to Arm(s): N/A

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized Clinical Trial of the Effect of Five-years Versus Two-years Specialized Assertive Intervention for First Episode Psychosis - the OPUS II Trial
Brief Summary: In a randomized clinical trial, the researchers want to investigate if the positive short-term outcomes (first 1-2 years), achieved with specialized assertive intervention programme (OPUS), can be maintained for five years if the specialized treatment is sustained over the first five years in comparison to only two years of specialized treatment followed by three years of standard treatment.


Options:
A: Arm Label: Integrated Treatment; Type: EXPERIMENTAL; Interventions: Behavioral: Integrated Treatment | Arm Label: Community Care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Community Care | Intervention Type: BEHAVIORAL; Name: Integrated Treatment; Assigned to Arm(s): Integrated Treatment | Intervention Type: BEHAVIORAL; Name: Community Care; Assigned to Arm(s): Community Care
B: Arm Label: case management (4 yrs); Type: EXPERIMENTAL; Interventions: Behavioral: stage-specific case-management | Arm Label: case management (2 yrs) and standard care (2 yrs); Type: ACTIVE_COMPARATOR; Interventions: Behavioral: stage-specific case-management | Arm Label: standard care (4 yrs); Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: stage-specific case-management; Assigned to Arm(s): case management (2 yrs) and standard care (2 yrs), case management (4 yrs)
C: Arm Label: Case Management (1 year); Type: EXPERIMENTAL; Interventions: Behavioral: Community Case Management | Arm Label: Standard Care (1 year); Type: NO_INTERVENTION; Interventions: Behavioral: Community Case Management | Intervention Type: BEHAVIORAL; Name: Community Case Management; Assigned to Arm(s): Case Management (1 year), Standard Care (1 year)
D: Arm Label: 5 year; Type: EXPERIMENTAL; Interventions: Behavioral: OPUS 5 years | Arm Label: 2 years of OPUS treatment; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: 2 years OPUS treatment | Intervention Type: BEHAVIORAL; Name: 2 years OPUS treatment; Assigned to Arm(s): 2 years of OPUS treatment | Intervention Type: BEHAVIORAL; Name: OPUS 5 years; Assigned to Arm(s): 5 year

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized Clinical Trial of the Effect of Five-years Versus Two-years Specialized Assertive Intervention for First Episode Psychosis - the OPUS II Trial
Brief Summary: In a randomized clinical trial, the researchers want to investigate if the positive short-term outcomes (first 1-2 years), achieved with specialized assertive intervention programme (OPUS), can be maintained for five years if the specialized treatment is sustained over the first five years in comparison to only two years of specialized treatment followed by three years of standard treatment.


Options:
A: Arm Label: Functional remediation; Type: EXPERIMENTAL; Interventions: Behavioral: Functional remediation | Arm Label: Psychoeducation; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Psychoeducation | Arm Label: Treatment as Usual; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Treatment as usual | Intervention Type: BEHAVIORAL; Name: Functional remediation; Assigned to Arm(s): Functional remediation | Intervention Type: BEHAVIORAL; Name: Psychoeducation; Assigned to Arm(s): Psychoeducation | Intervention Type: BEHAVIORAL; Name: Treatment as usual; Assigned to Arm(s): Treatment as Usual
B: Arm Label: 5 year; Type: EXPERIMENTAL; Interventions: Behavioral: OPUS 5 years | Arm Label: 2 years of OPUS treatment; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: 2 years OPUS treatment | Intervention Type: BEHAVIORAL; Name: 2 years OPUS treatment; Assigned to Arm(s): 2 years of OPUS treatment | Intervention Type: BEHAVIORAL; Name: OPUS 5 years; Assigned to Arm(s): 5 year
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Cognitive enhancement therapy (CET) | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Enriched supportive therapy (EST) | Intervention Type: BEHAVIORAL; Name: Cognitive enhancement therapy (CET); Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Enriched supportive therapy (EST); Assigned to Arm(s): 2
D: Intervention Type: PROCEDURE; Name: Individual placement and support (vocational rehabilitation); Assigned to Arm(s): N/A

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Multi-Centre, Randomised, Double-Blind, Placebo Controlled Trial on Efficacy and Safety of FXIII Replenishment With Two Different Doses of Recombinant Factor XIII Following Cardiopulmonary Bypass Surgery
Brief Summary: This trial is conducted in Canada, Asia, Europe and USA. The aim of this clinical trial is to investigate the effect and safety of rFXIII on transfusion needs in patients undergoing heart surgery.


Options:
A: Arm Label: Haemocomplettan® P; Type: ACTIVE_COMPARATOR; Interventions: Biological: Haemocomplettan® P | Arm Label: Saline solution; Type: PLACEBO_COMPARATOR; Interventions: Biological: Saline solution | Intervention Type: BIOLOGICAL; Name: Haemocomplettan® P; Assigned to Arm(s): Haemocomplettan® P | Intervention Type: BIOLOGICAL; Name: Saline solution; Assigned to Arm(s): Saline solution
B: Arm Label: Fibrinogen if FibTEM < 8 mm; Type: ACTIVE_COMPARATOR; Interventions: Drug: Human fibrinogen concentrate | Arm Label: Fibrinogen if FibTEM < 13 mm; Type: EXPERIMENTAL; Interventions: Drug: Human fibrinogen concentrate | Intervention Type: DRUG; Name: Human fibrinogen concentrate; Assigned to Arm(s): Fibrinogen if FibTEM < 13 mm, Fibrinogen if FibTEM < 8 mm
C: Arm Label: FXIII17.5IU/Kg; Type: EXPERIMENTAL; Interventions: Drug: catridecacog | Arm Label: FXIII35IU/Kg; Type: EXPERIMENTAL; Interventions: Drug: catridecacog | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Intervention Type: DRUG; Name: catridecacog; Assigned to Arm(s): FXIII17.5IU/Kg | Intervention Type: DRUG; Name: catridecacog; Assigned to Arm(s): FXIII35IU/Kg | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): Placebo
D: Arm Label: Albumin; Type: PLACEBO_COMPARATOR; Interventions: Drug: Human albumin (Placebo) | Arm Label: Haemocomplettan® P; Type: EXPERIMENTAL; Interventions: Drug: Haemocomplettan® P | Intervention Type: DRUG; Name: Haemocomplettan® P; Assigned to Arm(s): Haemocomplettan® P | Intervention Type: DRUG; Name: Human albumin (Placebo); Assigned to Arm(s): Albumin

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Is Adaptive Servo-Ventilation Therapeutically More Effective Than Continuous Positive Airway Pressure In Treating Complex Sleep Apnea Syndrome?
Brief Summary: The purpose of this study is to determine whether adaptive servo-ventilation (ASV) or continuous positive airway pressure (CPAP) is better at treating complex sleep apnea over time.


Options:
A: Arm Label: Treatment Group; Type: ACTIVE_COMPARATOR; Interventions: Device: Europe: AutoSet CS (USA: VPAP Adapt SV) | Arm Label: Control Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Europe: AutoSet CS (USA: VPAP Adapt SV); Assigned to Arm(s): Treatment Group
B: Arm Label: Nocturnal oxygen therapy; Type: ACTIVE_COMPARATOR; Interventions: Device: Nocturnal oxygen | Arm Label: Adaptive servo ventilation; Type: ACTIVE_COMPARATOR; Interventions: Device: Adaptive servo ventilation | Intervention Type: DEVICE; Name: Adaptive servo ventilation; Assigned to Arm(s): Adaptive servo ventilation | Intervention Type: DEVICE; Name: Nocturnal oxygen; Assigned to Arm(s): Nocturnal oxygen therapy
C: Arm Label: Bilevel; Type: ACTIVE_COMPARATOR; Interventions: Device: Bilevel therapy (somnovent ST 22, Weinmann, Hamburg, Germany) | Arm Label: Servoventilation; Type: ACTIVE_COMPARATOR; Interventions: Device: servoventilation (Somnovent CR, Weinmann, Hamburg, Germany) | Intervention Type: DEVICE; Name: Bilevel therapy (somnovent ST 22, Weinmann, Hamburg, Germany); Assigned to Arm(s): Bilevel | Intervention Type: DEVICE; Name: servoventilation (Somnovent CR, Weinmann, Hamburg, Germany); Assigned to Arm(s): Servoventilation
D: Arm Label: ASV mode; Type: ACTIVE_COMPARATOR; Interventions: Device: VPAP Adapt SV | Arm Label: CPAP mode; Type: ACTIVE_COMPARATOR; Interventions: Device: VPAP Adapt SV | Intervention Type: DEVICE; Name: VPAP Adapt SV; Assigned to Arm(s): ASV mode, CPAP mode

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Multi-center, Randomized, Parallel Group, Double-blind, Vehicle-controlled Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel, 0.015% In Patients With Actinic Keratoses ON the Head (Face or Scalp) (REGION-IIb)
Brief Summary: This Phase III study is designed to assess the efficacy and safety of PEP005 Gel, 0.015% when applied to an area of skin containing 4-8 AK lesions on the face or scalp.


Options:
A: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: PEP005 (ingenol mebutate) Gel | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: Vehicle gel | Intervention Type: DRUG; Name: PEP005 (ingenol mebutate) Gel; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Vehicle gel; Assigned to Arm(s): 2
B: Arm Label: PEP005 gel; Type: EXPERIMENTAL; Interventions: Drug: PEP005 Gel | Arm Label: Vehicle gel; Type: PLACEBO_COMPARATOR; Interventions: Drug: Vehicle gel | Intervention Type: DRUG; Name: PEP005 Gel; Assigned to Arm(s): PEP005 gel | Intervention Type: DRUG; Name: Vehicle gel; Assigned to Arm(s): Vehicle gel
C: Arm Label: PEP005 (Ingenol Mebutate) gel; Type: EXPERIMENTAL; Interventions: Drug: PEP005 (Ingenol Mebutate) gel, 0.015% | Arm Label: Vehicle gel; Type: PLACEBO_COMPARATOR; Interventions: Drug: Vehicle Gel | Intervention Type: DRUG; Name: PEP005 (Ingenol Mebutate) gel, 0.015%; Assigned to Arm(s): PEP005 (Ingenol Mebutate) gel | Intervention Type: DRUG; Name: Vehicle Gel; Assigned to Arm(s): Vehicle gel
D: N/A

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Multi-center, Randomized, Parallel Group, Double-blind, Vehicle-controlled Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel, 0.015% In Patients With Actinic Keratoses ON the Head (Face or Scalp) (REGION-IIa)
Brief Summary: This Phase III study is designed to assess the efficacy and safety of PEP005 Gel, 0.015% when applied to an area of skin containing 4-8 AK lesions on the face or scalp.


Options:
A: Arm Label: PEP005 (ingenol mebutate) Gel; Type: ACTIVE_COMPARATOR; Interventions: Drug: PEP005 (ingenol mebutate) Gel | Arm Label: Vehicle gel; Type: PLACEBO_COMPARATOR; Interventions: Drug: Vehicle gel | Intervention Type: DRUG; Name: PEP005 (ingenol mebutate) Gel; Assigned to Arm(s): PEP005 (ingenol mebutate) Gel | Intervention Type: DRUG; Name: Vehicle gel; Assigned to Arm(s): Vehicle gel
B: Arm Label: PEP005 gel; Type: EXPERIMENTAL; Interventions: Drug: PEP005 Gel | Arm Label: Vehicle gel; Type: PLACEBO_COMPARATOR; Interventions: Drug: Vehicle gel | Intervention Type: DRUG; Name: PEP005 Gel; Assigned to Arm(s): PEP005 gel | Intervention Type: DRUG; Name: Vehicle gel; Assigned to Arm(s): Vehicle gel
C: N/A
D: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: PEP005 (ingenol mebutate) Gel | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: Vehicle gel | Intervention Type: DRUG; Name: PEP005 (ingenol mebutate) Gel; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Vehicle gel; Assigned to Arm(s): 2

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Multisystemic Therapy to Reduce Health Disparities in Adolescents With Asthma
Brief Summary: Asthma is a chronic lung disease that inflames and narrows the airways. Symptoms can include recurring periods of wheezing, chest tightness, shortness of breath, and coughing. Minority, inner city teens are at increased risk for complications from the disease, possibly because of poor illness management. The purpose of this study is to test the effectiveness of Multisystemic Therapy (MST)-an intensive, home- and community-based psychotherapy-for improving asthma management and overall health and for reducing healthcare costs for inner city African American teens with asthma.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Multisystemic Therapy | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Home-based, Non-Directive Family Support | Intervention Type: BEHAVIORAL; Name: Multisystemic Therapy; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Home-based, Non-Directive Family Support; Assigned to Arm(s): 2
B: Arm Label: CampAir Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: CampAir | Arm Label: Information and Referral Control; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Information and Referral | Intervention Type: BEHAVIORAL; Name: CampAir; Assigned to Arm(s): CampAir Intervention | Intervention Type: BEHAVIORAL; Name: Information and Referral; Assigned to Arm(s): Information and Referral Control
C: Arm Label: I Can Cope Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: I Can Cope Intervention | Arm Label: Standard Education Intervention; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Standard Education Intervention | Arm Label: No treatment control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: I Can Cope Intervention; Assigned to Arm(s): I Can Cope Intervention | Intervention Type: BEHAVIORAL; Name: Standard Education Intervention; Assigned to Arm(s): Standard Education Intervention
D: Arm Label: End User Iterative Testing - CampAir; Type: OTHER; Interventions: Behavioral: CampAir | Intervention Type: BEHAVIORAL; Name: CampAir; Assigned to Arm(s): End User Iterative Testing - CampAir

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Overweight and Obesity in Preschool Children, Prevalence and Prevention - Family Based Health Interventions for Child Health
Brief Summary: To evaluate the effects of a family-based intervention program intended for parents of pre-school children (4-6 y) with overweight and obesity (according to Cole et al), and to investigate if treatment has an effect on metabolic parameters. In a randomised controlled trial evaluate the three separate family based intervention programs and to investigate if treatment has an effect by correlating the parameters described above with BMI, before and after the intervention program.


Options:
A: Arm Label: 1M0.5; Type: EXPERIMENTAL; Interventions: Other: Timing of Diet and Flavor Experience | Arm Label: 1M1.5; Type: EXPERIMENTAL; Interventions: Other: Timing of Diet and Flavor Experience | Arm Label: 3M0.5; Type: EXPERIMENTAL; Interventions: Other: Timing of Diet and Flavor Experience | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Timing of Diet and Flavor Experience; Assigned to Arm(s): 1M0.5, 1M1.5, 3M0.5
B: Arm Label: A: experimental; Type: EXPERIMENTAL; Interventions: Behavioral: Obesity-Children | Arm Label: (B): experimental; Type: EXPERIMENTAL; Interventions: Behavioral: Obesity-Children | Arm Label: (c): experimental; Type: EXPERIMENTAL; Interventions: Behavioral: Obesity-Children | Arm Label: (D): control group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Obesity-Children | Intervention Type: BEHAVIORAL; Name: Obesity-Children; Assigned to Arm(s): (B): experimental, (D): control group, (c): experimental, A: experimental
C: Arm Label: Mobile phone based intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Mobile phone based intervention | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Mobile phone based intervention; Assigned to Arm(s): Mobile phone based intervention
D: Arm Label: Arm 1; Type: EXPERIMENTAL; Interventions: Behavioral: Primary (Environmental) Weight Gain Prevention | Arm Label: Arm 2; Type: EXPERIMENTAL; Interventions: Behavioral: Primary (Environmental) Weight Gain Prevention, Behavioral: Secondary (Behavioral) Weight Gain Prevention | Arm Label: Arm 3; Type: EXPERIMENTAL; Interventions: Behavioral: Control | Intervention Type: BEHAVIORAL; Name: Primary (Environmental) Weight Gain Prevention; Assigned to Arm(s): Arm 1, Arm 2 | Intervention Type: BEHAVIORAL; Name: Secondary (Behavioral) Weight Gain Prevention; Assigned to Arm(s): Arm 2 | Intervention Type: BEHAVIORAL; Name: Control; Assigned to Arm(s): Arm 3

Answer: B